WeTrials
WeTrials/LinkedIn

Insights on Biomarkers and Biomarker-Based Clinical Trials – WeTrials

WeTrials shared a post on LinkedIn:

“What Are Biomarkers?

When you’re facing a brain tumor diagnosis, there are more questions than answers. Biomarkers are one of the most powerful tools helping us find clarity.

They are measurable signs in your body — proteins in your blood, genetic changes in your cells, or clues from your scans. These markers help doctors:

  • See if treatments are working faster
  • Move from ‘one-size-fits-all’ to personalized care
  • Bridge the gap between science and patient care in clinical trials

This is the first video in our new series on biomarkers. Each short will dive deeper into:

  1. Types of biomarkers and what they reveal
  2. How biomarker testing shapes treatment decisions
  3. The role of biomarkers in clinical trials
  4. What patients and caregivers should know when asking about biomarker testing

Because you are more than a diagnosis. Your care should reflect you.

Follow along as we share more insights in this series and visit to explore biomarker-based clinical trials.”

Proceed to the video attached to the post.

More posts featuring WeTrials.